Talk:Brentuximab vedotin

Focus
The article currently focuses largely on the regulatory history of this drug in the U.S. It might be useful to include more of the actual published medical literature on the drug's efficacy, side effects, etc. I'll come back to this in the next couple of days and add some material. MastCell Talk 06:42, 11 September 2011 (UTC)

Here are some sources: I'll work on getting these into the article in the near future... MastCell Talk 22:14, 11 September 2011 (UTC)
 * ALCL:
 * Hodgkin lymphoma:
 * All CD30+ malignancies:
 * Mechanisms:
 * All CD30+ malignancies:
 * Mechanisms:
 * Mechanisms:

Side effects
More PML Cases Turn Up With Adcetris Three cases of progressive multifocal leukoencephalopathy prompt FDA to ask for boxed warning. - Rod57 (talk) 03:27, 14 January 2012 (UTC)

Linker
Apparently it uses the same valine-citrulline enzyme-cleavable linker as CDX-011. - Rod57 (talk) 01:16, 4 February 2013 (UTC)


 * Also - the Design section could clarify if/that there are also 3-5 copies of the attachment group, linker and spacer (as well as the MMAE). Also confirm if/that the attachment group attaches to cysteine in the MAB, and explain why only 3 to 5 (rather than all the suitable attachment points). - Rod57 (talk) 13:34, 14 November 2017 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified 1 one external link on Brentuximab vedotin. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive https://web.archive.org/web/20130525175719/http://www.adcetris.com:80/pdf/ADCETRIS_Prescribing_Information.pdf to http://www.adcetris.com/pdf/ADCETRIS_Prescribing_Information.pdf

When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at ).

Cheers.— InternetArchiveBot  (Report bug) 23:54, 7 November 2016 (UTC)

External links modified
Hello fellow Wikipedians,

I have just modified one external link on Brentuximab vedotin. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive https://web.archive.org/web/20131217230326/http://adcreview.com/profiles/blogs/brentuximab-vedotin-shows-42-objective-response-rate-in-patients- to http://adcreview.com/profiles/blogs/brentuximab-vedotin-shows-42-objective-response-rate-in-patients-

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Cheers.— InternetArchiveBot  (Report bug) 06:21, 25 July 2017 (UTC)

Has UK NICE considered it
Has UK NICE considered it ? - Rod57 (talk) 13:38, 14 November 2017 (UTC)

Copyright violations
Per Copyright_problems/2020_February_28, most of the "Development and marketing collaboration" section was pasted from this 2011 press release in a June 2013 edit. I blanked it for now. The other text added in that same edit is also worth investigating, but I can't find another source for it. Ajpolino (talk) 06:52, 9 October 2020 (UTC)